Welcome to LookChem.com Sign In|Join Free
  • or
N-[3-(2-ethoxy-2-hydroxyacetyl)-phenyl]-benzenesulphonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

868601-06-3

Post Buying Request

868601-06-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

868601-06-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 868601-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,6,0 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 868601-06:
(8*8)+(7*6)+(6*8)+(5*6)+(4*0)+(3*1)+(2*0)+(1*6)=193
193 % 10 = 3
So 868601-06-3 is a valid CAS Registry Number.

868601-06-3Relevant academic research and scientific papers

Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs

-

Page/Page column 7, (2008/12/04)

Compounds of the formula which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: ethyl 3-{3-[(R)-2-(3-benzenesulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-3H-imidazo[4,5-b]p

Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments

-

Page/Page column 9, (2009/01/20)

Compounds of general formula (I) which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)

Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 10, (2010/11/27)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 11-12, (2010/11/27)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,

Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions

-

Page/Page column 14, (2010/02/14)

The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R7 have the meanings given in the claims and specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof, t

NOVEL BETA AGONISTS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS

-

Page/Page column 35, (2010/02/14)

The invention relates to the novel beta agonists of general formula (I); wherein the groups R1 to R7 are defined as in the claims and the description, and to the tautomers, enantiomers, diastereomers, mixtures, prodrugs and salts the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 868601-06-3